Taken together, our results indicate that GATA3-AS1 is a luminal B-specific lncRNA that is associated with pCR and that its overexpression has predictive value for NAC resistance in luminal B breast cancer patients, but its adjacent gene, GATA3, is not a predictive biomarker in this group of patients. The gene discussed is GATA3; the disease is breast carcinoma.